Antlia Bioscience
Dr. Kalindjian is a synthetic and medicinal chemist with peptide/protein half-life extension expertise as well as vast, small- molecule drug discovery and development experience gained within numerous therapeutic areas. Dr. Kalindjian was formerly with Beecham Pharmaceuticals, CEO/Research Director at James Black Foundation Ltd and Head of Drug Discovery at Norgin.
This person is not in the org chart
This person is not in any teams
This person is not in any offices